Apitoria Pharma Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Unit-II, Survey No. 10 & 13, Gaddapotharam Village IDA- Kazipally, Jinnaram Mandal, Sangareddy, Telangana 502319, India (IND)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3004086884 · DUNS 918917662
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-09-27
- VAIDrug Quality Assurance2019-10-25
- NAIDrug Quality Assurance2018-06-11
- VAIDrug Quality Assurance2016-07-01
- VAIDrug Quality Assurance2014-04-19
- VAIDrug Quality Assurance2011-05-26
Drugs this plant is listed as making
2 distinct drugs across 3 products name this site in their FDA label.
- BUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.
- MoxifloxacinAurobindo Pharma Limited
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.